Ltztherapeutics
Redwood City, US · Founded 2022 · 46 employees on LinkedIn · 1 known investors
Find your way into Ltztherapeutics
Sign up to see every warm intro you have to Ltztherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ltztherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LTZ Therapeutics is an immunotherapy biotech developing treatments for oncology and autoimmune diseases using a myeloid cell engager approach centered on macrophages. It operates a Myeloid Engager Platform and has entered development collaborations with large pharmaceutical companies.
Founders & leadership
Ltztherapeutics was founded in 2022 by Robert Li.
Investors · 1
Qiming Venture Partnerslisted by Qiming Venture PartnersBeijing
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Ltztherapeutics do?
- LTZ Therapeutics is an immunotherapy biotech developing treatments for oncology and autoimmune diseases using a myeloid cell engager approach centered on macrophages. It operates a Myeloid Engager Platform and has entered development collaborations with large pharmaceutical companies.
- Who founded Ltztherapeutics?
- Ltztherapeutics was founded by Robert Li in 2022.
- Who are Ltztherapeutics's investors?
- Ltztherapeutics's investors include Qiming Venture Partners.
- Where is Ltztherapeutics headquartered?
- Ltztherapeutics is headquartered in Redwood City, US.


